Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5128-5136

  Skwor, Troy ^a,b   Kandel, Ram Prasad ^c   Basravi, Sunniya ^a   Khan, Aslam ^a   Sharma, Bassant ^c   Dean, Deborah ^a,d,e,f  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b GANNON UNIVERSITY   (United States)

^c Lumbini Rana Ambika Eye Hospital   (Nepal)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHLAMYDIAL PROTEASE ASSOCIATED FACTOR; CT795 PROTEIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CHAPERONIN; HYBRID PROTEIN; IMMUNOGLOBULIN G; PRIMER DNA; PROTEINASE; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; NEPAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TRACHOMA; TRICHIASIS; CHEMISTRY; IMMUNOLOGY; LACRIMAL FLUID; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHAPERONIN 60; CHILD; CHLAMYDIA TRACHOMATIS; DNA PRIMERS; ENDOPEPTIDASES; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; TEARS; TRACHOMA;

EID: 77958116988     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5113     Document Type: Article

References (68)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82: 844-851.
2. Dean D, Kandel RP, Adhikari HK, Hessel T. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Med. 2008;5:e14.
3. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004;292:721-725.
4. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA. 2006;296:1488-1497.
5. Zhang H, Kandel RP, Sharma B, Dean D. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Arch Ophthalmol. 2004;122:511-516.
6. West ES, Mkocha H, Munoz B, et al. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci. 2005;46:447-453.
7. Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, Caldwell HD. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun. 1995;63:4704-4714.
8. Morrison SG, Su H, Caldwell HD, Morrison RP. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun. 2000; 68:6979-6987.
9. Moore T, Ananaba GA, Bolier J, et al. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology. 2002;105:213-221.
10. Ito JI, Lyons JM. Role of gamma interferon in controlling murine chlamydial genital tract infection. Infect Immun. 1999;67:5518-5521.
11. Young E, Taylor HR. Immune mechanisms in chlamydial eye infection: cellular immune responses in chronic and acute disease. J Infect Dis. 1984;150:745-751.
12. el-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah MH, Desmet V. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol. 1989;73:276-282.
13. Skwor TA, Atik B, Kandel RP, Adhikari HK, Sharma B, Dean D. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease. PLoS Negl Trop Dis. 2008;2:e264.
14. Rank RG, Soderberg LS, Barron AL. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun. 1985; 48:847-849.
15. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun. 1991;59: 925-931.
16. Hawkins RA, Rank RG, Kelly KA. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect Immun. 2002;70:5132-5139.
17. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun. 1997;65:2175-2182.
18. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J Infect Dis. 1996; 174:647-650.
19. Patton DL, Taylor HR. The histopathology of experimental trachoma: ultrastructural changes in the conjunctival epithelium. J Infect Dis. 1986;153:870-878.
20. Bobo L, Novak N, Mkocha H, Vitale S, West S, Quinn TC. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun. 1996;64: 3273-3279.
21. Ghaem-Maghami S, Bailey RL, Mabey DC, et al. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect Immun. 1997;65:4958-4964.
22. Hessel T, Dhital SP, Plank R, Dean D. Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients. Infect Immun. 2001;69:4996-5000.
23. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J Infect Dis. 1993; 168:1528-1531.
24. Peeling RW, Bailey RL, Conway DJ, et al. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis. 1998;177:256-259.
25. Tan C, Hsia RC, Shou H, et al. Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect Immun. 2009;77: 3218-3226.
26. Gomes JP, Hsia RC, Mead S, Borrego MJ, Dean D. Immunoreactivity and differential developmental expression of known and putative Chlamydia trachomatis membrane proteins for biologically variant serovars representing distinct disease groups. Microbes Infect. 2005;7:410-420.
27. Comanducci M, Manetti R, Bini L, et al. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun. 1994;62:5491-5497.
28. Crane DD, Carlson JH, Fischer ER, et al. Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A. 2006;103:1894-1899.
29. Byrne GI, Stephens RS, Ada G, et al. Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J Infect Dis. 1993;168:415-420.
30. Eckert LO, Hawes SE, Wolner-Hanssen P, et al. Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis. 1997;175: 1453-1458.
31. Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis. 2008;35:129-135.
32. Money DM, Hawes SE, Eschenbach DA, et al. Antibodies to the chlamydial 60 kd heat-shock protein are associated with laparoscopically confirmed perihepatitis. Am J Obstet Gynecol. 1997; 176:870-877.
33. Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis. 1997;175:1153-1158.
34. Paavonen J, Lehtinen M. Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer. Curr Opin Infect Dis. 1999;12:67-71.
35. Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001;193:935-942.
36. Murthy AK, Cong Y, Murphey C, et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLADR4 allele. Infect Immun. 2006;74:6722-6729.
37. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun. 2007; 75:666-676.
38. Sharma J, Dong F, Pirbhai M, Zhong G. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis. Infect Immun. 2005;73:4414-4419.
39. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun. 2006;74:1490-1499.
40. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65:477-483.
41. Murray AM, Kelly CD, Nussey SS, Johnstone AP. Production of glutathione-coated microtitre plates for capturing recombinant glutathione S-transferase fusion proteins as antigens in immunoassays. J Immunol Methods. 1998;218:133-139.
42. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005;5:149-161.
43. Bax CJ, Dorr PJ, Trimbos JB, et al. Chlamydia trachomatis heat shock protein 60 (cHSP60) antibodies in women without and with tubal pathology using a new commercially available assay. Sex Transm Infect. 2004;80:415-416.
44. Sziller I, Fedorcsak P, Csapo Z, et al. Circulating antibodies to a conserved epitope of the Chlamydia trachomatis 60-kDa heat shock protein is associated with decreased spontaneous fertility rate in ectopic pregnant women treated by salpingectomy. Am J Reprod Immunol. 2008;59:99-104.
45. Dean D, Powers VC. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infect Immun. 2001;69:2442-2447.
46. Campanella C, Marino Gammazza A, Mularoni L, Cappello F, Zummo G, Di Felice V. A comparative analysis of the products of GROEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int J Immunogenet. 2009;36:73-78.
47. Tiitinen A, Surcel HM, Halttunen M, et al. Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cellmediated responses predict tubal factor infertility. Hum Reprod. 2006;21:1533-1538.
48. Kuipers JG, Sibilia J, Bas S, et al. Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis. Clin Rheumatol. 2009;28:11-16.
49. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999;283:1335-1339.
50. Arno JN, Yuan Y, Cleary RE, Morrison RP. Serologic responses of infertile women to the 60-kd chlamydial heat shock protein (hsp60). Fertil Steril. 1995;64:730-735.
51. Yi Y, Zhong G, Brunham RC. Continuous B-cell epitopes in Chlamydia trachomatis heat shock protein 60. Infect Immun. 1993; 61:1117-1120.
52. Rosenberg HF, Morrison RP, Li F. Identification of a 40-kDa human protein that cross-reacts with prokaryotic hsp60/chaperonins. Biochem Biophys Res Commun. 1995;208:697-703.
53. Pal S, Taylor HR, Huneke RB, Prendergast RA, Whittum-Hudson JA. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection. Infect Immun. 1992;60:5294-5297.
54. Dean D. Pathogenesis of chlamydia ocular infections. In: Tasman W, Jaeger EA, eds. Duane's Foundations of Clinical Ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2010. In press.
55. Tabbara KF, Bobb AA. Lacrimal system complications in trachoma. Ophthalmology. 1980;87:298-301.
56. el-Asrar AM, Geboes K, al-Kharashi SA, et al. An immunohistochemical study of collagens in trachoma and vernal keratoconjunctivitis. Eye. 1998;12:1001-1006.
57. Webley WC, Vora GJ, Stuart ES. Cell surface display of the chlamydial glycolipid exoantigen (GLXA) demonstrated by antibody-dependent complement-mediated cytotoxicity. Curr Microbiol. 2004;49:13-21.
58. Pal S, Pu Z, Huneke RB, Taylor HR, Whittum-Hudson JA. Chlamydia- specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis. Reg Immunol. 1990-91;3:171-176.
59. Whittum-Hudson JA, Taylor HR, Farazdaghi M, Prendergast RA. Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci. 1986;27: 64-69.
60. Taylor HR, Maclean IW, Brunham RC, Pal S, Wittum-Hudson J. Chlamydial heat shock proteins and trachoma. Infect Immun. 1990;58:3061-3063.
61. Patton DL, Sweeney YT, Kuo CC. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage. J Infect Dis. 1994;169: 680-683.
62. Frikha-Gargouri O, Gdoura R, Znazen A, Gargouri J, Hammami A. Diagnostic value of enzyme-linked immunosorbent assays using hypothetical proteins CT226 and CT795 as antigens in Chlamydia trachomatis serodiagnosis. Diagn Microbiol Infect Dis. 2009;65: 224-231.
63. Sharma J, Bosnic AM, Piper JM, Zhong G. Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun. 2004;72:7164-7171.
64. Kawana K, Quayle AJ, Ficarra M, et al. CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem. 2007;282:7368-7375.
65. Dong F, Su H, Huang Y, Zhong Y, Zhong G. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun. 2004; 72:3863-3868.
66. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem. 2006;281:31495-31501.
67. Li W, Murthy AK, Guentzel MN, et al. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. J Immunol. 2008;180:3375-3382.
68. Paschen SA, Christian JG, Vier J, et al. Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease. J Cell Biol. 2008;182:117-127.